ImmunoPrecise Antibodies Overview

  • Founded
  • 1989
Founded
  • Status
  • Public
  • Stock Symbol
  • IPA
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $7.50
  • (As of Thursday Closing)

ImmunoPrecise Antibodies General Information

Description

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.

Contact Information

Website
www.immunoprecise.com
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Stock Exchange
TSX
Primary Office
  • Vancouver Island Technology Park
  • Unit 3204-4464 Markham Street
  • Victoria, British Columbia V8Z 7X8
  • Canada
+1 (250) 000-0000

ImmunoPrecise Antibodies Timeline

2017201820192020
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunoPrecise Antibodies Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.50 $7.16 $1.89 - $11.73 $120M 16.8M 99K -$0.19

ImmunoPrecise Antibodies Financials Summary

In Thousands,
USD 		TTM 31-Jul-2020 FY 2020 30-Apr-2020 FY 2019 30-Apr-2019 FY 2018 30-Apr-2018
EV 79,837 40,099 35,706 41,134
Revenue 11,224 10,526 8,291 4,258
EBITDA 223 (1,213) (3,768) (3,619)
Net Income (2,589) (3,705) (5,780) (4,046)
Total Assets 24,912 19,647 21,152 19,133
Total Debt 3,746 3,250 2,175 2,979
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ImmunoPrecise Antibodies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ImmunoPrecise Antibodies‘s full profile, request access.

Request a free trial

ImmunoPrecise Antibodies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The c
Biotechnology
Victoria, Canada
000.00
000000000 000.00

00000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut e
0000000000000
Cranbury, NJ

00000000

a pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt molli
0000000000000
Shirley, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImmunoPrecise Antibodies Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PeproTech Corporation Cranbury, NJ
00000000 000000000 Corporation Shirley, NY
000000000 Formerly VC-backed Piscataway Township, NJ 0000 00000 00000000 00000
000000000000 Corporate Backed or Acquired Morris Plains, NJ 000 00000 000000&0 00000
To view ImmunoPrecise Antibodies’s complete competitors history, request access »

ImmunoPrecise Antibodies Executive Team (8)

Name Title Board Seat Contact Info
Jennifer Bath Ph.D Chief Executive Officer & Board Member
Natasha Tsai Chief Financial Officer
David Orton Chief Operating Officer
Yasmina Abdiche Ph.D Chief Scientific Officer
You’re viewing 4 of 8 executive team members. Get the full list »

ImmunoPrecise Antibodies Board Members (5)

Name Representing Role Since
0000 00000 Self Board Member 000 0000
00000 000 00 ImmunoPrecise Antibodies Chairman 000 0000
00000000 0000 00.0 ImmunoPrecise Antibodies Chief Executive Officer & Board Member 000 0000
0000 00000000 Self Board Member 000 0000
To view ImmunoPrecise Antibodies’s complete board members history, request access »

ImmunoPrecise Antibodies Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 06-Apr-2018 000000000000000000 00.000 Discovery Tools (Healthcare) 00000 000 00
000000000 00000000 30-Jan-2018 000000000000000000 000.00 Drug Discovery 00000 000 00
0000000 29-Dec-2017 000000000 00000 Discovery Tools (Healthcare) 00000 000 00
0000000000 28-Dec-2017 000000000000000000 00.000 Other Healthcare 00000 000 00
QVQ Holdings 02-Oct-2017 Merger/Acquisition 00000 Biotechnology 000000 00000000
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

ImmunoPrecise Antibodies Subsidiaries (5)

Company Name Industry Location Founded
Preclinics Other Healthcare Potsdam, Germany 2007
0-0000000 0000000 Biotechnology Utrecht, Netherlands 0000
000000000 00000000 Drug Discovery Utrecht, Netherlands 0000
000000000 00000000 Discovery Tools (Healthcare) Oss, Netherlands 0000
000 00000000 Biotechnology Utrecht, Netherlands
To view ImmunoPrecise Antibodies’s complete subsidiaries history, request access »

ImmunoPrecise Antibodies Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 29-Dec-2017 000000000 00000 Completed
  • 0000000000000 0000
To view ImmunoPrecise Antibodies’s complete exits history, request access »